Silicon Valley / San Jose Business Journal:

jabire2389.blogspot.com
Museum of Contemporary Art, will assumwe her new responsibilities in San Josebeginning 15. She will oversee the museum’ds $5 million budget as well as a staff of32 full-timwe employees, 40 seasonal employees and 150 volunteers. Appointed in 2001 to the Scottsdaled post, Krane was formerly directorf of University of Colorado Art Museum in She succeedsDan Keegan, who resigned in Februaryg after seven years in the position to take over managementy of the Milwaukee Art Museum. Sunnyvale-based Liga Systems Inc. name d Jim Hogan to its board of directors.
Hogan has workedf in the semiconductor desigj and manufacturing industry for 33 serving as a senior executive in electronivdesign automation, semiconductor intellectual property, semiconductor equipmentf and fabrication companies. Hogan has held a varietyt of executive positions at severalpublic companies, including senior vice president of businessx development at Artisan Components and senior vice presidentt of business development and the seniorf member of the office of chie technologist at Cadence Design Systems Inc. San Jose-bases netCustomer Inc.
named Davird Hare chairman of the Hare has more than 30 years of enterprise softwaresupportr experience, most recently as the senior vice presiden t of global product support at Oraclee Corp. Before that he was group vice presiden t of support services atPeopleSoft Inc. Foster City-based Gileae Sciences Inc. named Dr. Richarfd J. Whitley to the board. He is a professor of microbiology, medicine and neurosurgery at the Universityy of Alabamaat Birmingham. Sunnyvale-based Aribz Inc. named Harriet Edelman to its boardeof directors. During a career that spanned more than 25 yearw at AvonProducts Inc.
, Edelman served in key leadership positions, including her most recent post as senio r vice president and chief information officer. Santaz Clara-based XenoPort Inc. named Per G. H. Lofbervg to its board of directors. Lofbery is currently chairman and a managing director of PharmaCapital Ventures. Until recently, he was president and chief executive officer of Merck Capita lVentures LLC.